|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.759 USD | +4.89% |
|
-5.12% | +5.86% |
| 14/05 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
| 13/05 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
VolitionRx Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 0.149808 million compared to USD 0.114211 million a year ago. Net loss was USD 8.78 million compared to USD 7.63 million a year ago.
Basic loss per share from continuing operations was USD 0.15 compared to USD 0.14 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.86% | 59.93M | |
| -31.71% | 9.87B | |
| -16.78% | 2.75B | |
| -17.50% | 2.13B | |
| -24.17% | 1.65B | |
| +67.10% | 1.47B | |
| +35.00% | 811M | |
| -5.02% | 733M | |
| -29.90% | 510M | |
| +0.20% | 300M |
VOLITIONRX LIMITED 
